C. Rantzau

发表

Effect of alcohol swabbing on capillary blood glucose measurements

P. Dunning, C. Rantzau, G. Ward, 1994 .

controlled alloxan-diabetic dogs glucose metabolism during exercise in poorly Prevailing hyperglycemia is critical in the regulation of

B. Kemp, C. Rantzau, G. McConell, 2015 .

Prevailing hyperglycemia is critical in the regulation of glucose metabolism during exercise in poorly controlled alloxan-diabetic dogs.

B. Kemp, C. Rantzau, G. McConell, 2005, Journal of applied physiology.

Impact of variable insulinemia and glycemia on in vivo glycolysis and glucose storage in dogs.

C. Rantzau, G. Ward, F. Alford, 1994, The American journal of physiology.

Glucose effectiveness and insulin sensitivity measurements derived from the non‐insulin‐assisted minimal model and the clamp techniques are concordant

R. Boston, C. Rantzau, G. Ward, 2010, Diabetes/metabolism research and reviews.

Contrasting effects of exercise, AICAR, and increased fatty acid supply on in vivo and skeletal muscle glucose metabolism.

C. Rantzau, F. Alford, M. Christopher, 2008, Journal of applied physiology.

The relationship between peripheral glucose utilisation and insulin sensitivity in the regulation of hepatic glucose production: studies in normal and alloxan‐diabetic dogs

C. Rantzau, F. Alford, M. Christopher, 2006, Diabetes/metabolism research and reviews.

Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.

B. Kemp, C. Rantzau, F. Alford, 2006, American journal of physiology. Endocrinology and metabolism.

Skeletal muscle basal AMP-activated protein kinase activity is chronically elevated in alloxan-diabetic dogs: impact of exercise.

B. Kemp, C. Rantzau, F. Alford, 2003, Journal of applied physiology.

The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10 years in relatives of type 2 diabetic subjects

C. Rantzau, G. Ward, H. Beck-Nielsen, 2013, Diabetes/metabolism research and reviews.

Defects of insulin action and skeletal muscle glucose metabolism in growth hormone-deficient adults persist after 24 months of recombinant human growth hormone therapy.

C. Rantzau, F. Alford, F. Hew, 1998, The Journal of clinical endocrinology and metabolism.

Insulin resistance in growth hormone-deficient adults: defects in glucose utilization and glycogen synthase activity.

A. Vaag, C. Rantzau, G. Ward, 1996, The Journal of clinical endocrinology and metabolism.

metabolism glucose fatty acid supply on in vivo and skeletal muscle Contrasting effects of exercise, AICAR, and increased

C. Rantzau, S. Warden, F. Alford, 2015 .

metabolismacid supply on in vivo and skeletal muscle glucose Contrasting effects of exercise, AICAR, and increased

C. Rantzau, F. Alford, M. Christopher, 2013 .

Increased glucose production in mice overexpressing human fructose-1,6-bisphosphatase in the liver.

C. Rantzau, J. Proietto, M. Watt, 2008, American journal of physiology. Endocrinology and metabolism.

Insulin sensitivity in growth hormone (GH)-deficient adults and effect of GH replacement therapy.

C. Rantzau, F. Alford, F. Hew, 1999, Journal of endocrinological investigation.

Effects of nitric oxide synthase blockade on dorsal vagal stimulation-induced pancreatic insulin secretion

C. Rantzau, A. Verberne, D. Sartor, 2011, Brain Research.

Fructose-1,6-bisphosphatase overexpression in pancreatic beta-cells results in reduced insulin secretion: a new mechanism for fat-induced impairment of beta-cell function.

D. R. Laybutt, C. Rantzau, J. Proietto, 2008, Diabetes.

Impact of family history of diabetes on the assessment of beta-cell function.

A. Vaag, C. Rantzau, G. Ward, 1998, Metabolism: clinical and experimental.

Insulin secretion in growth hormone-deficient adults: effects of 24 months' therapy and five days' acute withdrawal of recombinant human growth hormone.

C. Rantzau, G. Ward, F. Alford, 1999, Metabolism: clinical and experimental.

Effects of growth hormone deficiency and therapy in adults on skeletal muscle glucose metabolism, lipid profiles and regional body composition

C. Rantzau, G. Ward, D. Clemmons, 1995 .

Glucose effectiveness is a critical pathogenic factor leading to glucose intolerance and type 2 diabetes: An ignored hypothesis

C. Rantzau, H. Beck-Nielsen, J. Henriksen, 2018, Diabetes/metabolism research and reviews.

Endogenous incretin hormone augmentation of acute insulin secretion in normoglycemic relatives of type 2 diabetic subjects: a 10-year retrospective pathophysiological study.

C. Rantzau, H. Beck-Nielsen, J. Henriksen, 2014, The Journal of clinical endocrinology and metabolism.

Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion

D. R. Laybutt, C. Rantzau, J. Proietto, 2008, Diabetes.

Remodeling markers are associated with larger intracortical surface area but smaller trabecular surface area: a twin study.

J. Hopper, Tuan V. Nguyen, C. Rantzau, 2011, Bone.

skeletal muscle with elevated lactate concentration Lactate metabolism in resting and contracting canine

G. Brooks, S. Lehman, C. Rantzau, 2015 .

Impact of family history of diabetes on the assessment of β-cell function

A. Vaag, C. Rantzau, G. Ward, 1998 .

Insulinopenia and hyperglycemia influence the in vivo partitioning of GE and SI.

C. Rantzau, G. Ward, F. Alford, 1995, The American journal of physiology.

Glucose effectiveness in nondiabetic relatives: dysglycemia and β-cell function at 10 years.

C. Rantzau, G. Ward, H. Beck-Nielsen, 2014, The Journal of clinical endocrinology and metabolism.